Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03624036
Brief Title: Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ZUMA-8)

First Submitted : August 7, 2018
First Submitted that Met QC Criteria : August 7, 2018
First Posted : August 9, 2018

Last Update Submitted that Met QC Criteria : May 18, 2021
Last Update Posted : May 19, 2021